Redwood City Newswire

Redwood City Newswire

Comprehensive Real-Time News Feed for Redwood City, CA.

Results 1 - 20 of 215 for "u:americanbankingnews.com" in Redwood City, CA

  1. Dermira Inc (DERM) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Wednesday | AmericanBankingNews.com

    According to Zacks, "Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients.

    Comment?

  2. Dermira Inc (DERM) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Wednesday | AmericanBankingNews.com

    According to Zacks, "Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients.

    Comment?

  3. Research Analysts' Recent Ratings Updates for RelypsaRead the original story w/Photo

    Monday Jun 20 | AmericanBankingNews.com

    They now have a $20.00 price target on the stock. 6/16/2016 - Relypsa had its "outperform" rating reaffirmed by analysts at Wedbush.

    Comment?

  4. Investment Analysts' Recent Ratings Changes for DermiraRead the original story w/Photo

    Friday Jun 17 | AmericanBankingNews.com

    According to Zacks, "Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients.

    Comment?

  5. Dermira Inc (DERM) Upgraded by Zacks Investment Research to HoldRead the original story w/Photo

    Tuesday Jun 14 | AmericanBankingNews.com

    According to Zacks, "Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients.

    Comment?

  6. Dermira Inc (DERM) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Tuesday Jun 14 | AmericanBankingNews.com

    According to Zacks, "Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients.

    Comment?

  7. Analysts' Recent Ratings Updates for RelypsaRead the original story w/Photo

    Thursday Jun 9 | AmericanBankingNews.com

    They now have a $9.00 price target on the stock. 6/4/2016 - Relypsa had its "buy" rating reaffirmed by analysts at Wedbush.

    Comment?

  8. Versartis Inc (VSAR) Lowered to Sell at Zacks Investment ResearchRead the original story w/Photo

    Wednesday Jun 8 | AmericanBankingNews.com

    According to Zacks, "Versartis, Inc. operates as a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders.

    Comment?

  9. Avinger Inc (AVGR) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Wednesday Jun 1 | AmericanBankingNews.com

    According to Zacks, "Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox.

    Comment?

  10. Avinger Inc (AVGR) Upgraded to Hold at Zacks Investment ResearchRead the original story w/Photo

    Wednesday Jun 1 | AmericanBankingNews.com

    According to Zacks, "Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox.

    Comment?

  11. Investment Analysts' Updated EPS Estimates for June, 1st (AEE,...Read the original story w/Photo

    Wednesday Jun 1 | AmericanBankingNews.com

    According to Zacks, "Ameren Corp.'s first-quarter 2016 earnings surpassed the Zacks Consensus Estimate by 4.9% but were down 4.4% from the year-ago figure. Revenues also were down 7.8% year over year due to lower electric and gas sales volumes as a result of the warmer-than-usual winter in its service territories.

    Comment?

  12. Versartis Inc (VSAR) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Tuesday May 31 | AmericanBankingNews.com

    According to Zacks, "Versartis, Inc. operates as a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders.

    Comment?

  13. Recent Research Analysts' Ratings Updates for RelypsaRead the original story w/Photo

    Tuesday May 31 | AmericanBankingNews.com

    They now have a $51.00 price target on the stock. 5/27/2016 - Relypsa had its "underperform" rating reaffirmed by analysts at Mizuho.

    Comment?

  14. Zacks Investment Research Downgrades Avinger Inc (AVGR) to SellRead the original story w/Photo

    Wednesday May 25 | AmericanBankingNews.com

    According to Zacks, "Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox.

    Comment?

  15. Avinger Inc (AVGR) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Wednesday May 25 | AmericanBankingNews.com

    According to Zacks, "Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox.

    Comment?

  16. Stock Analysts' Updated EPS Estimates for May, 25th (ADVM, AIQUY,...Read the original story w/Photo

    Wednesday May 25 | AmericanBankingNews.com

    According to Zacks, "Adverum Biotechnologies, Inc. is a gene therapy company. The Company discovers and develops novel medicines for patients living with rare diseases.

    Comment?

  17. Research Analysts' Upgrades for May, 24th (AHCHY, ANH, AVX, BIN,...Read the original story w/Photo

    May 24, 2016 | AmericanBankingNews.com

    The firm currently has $13.00 target price on the stock. was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating.

    Comment?

  18. Capnia Inc (CAPN) Upgraded to Hold by Zacks Investment ResearchRead the original story w/Photo

    May 24, 2016 | AmericanBankingNews.com

    According to Zacks, "Capnia, Inc. is focused on the development and commercialization of therapeutic and diagnostic products to address unmet healthcare needs. It develops diagnostics based on its proprietary Sensalyze technology for precision metering of gas flow.

    Comment?

  19. Analysts' Updated EPS Estimates for May, 19th (ACAD, ASX, AVGR, ...Read the original story w/Photo

    May 19, 2016 | AmericanBankingNews.com

    According to Zacks, "Advanced Semiconductor Engineering, Inc. is an independent provider of semiconductor packaging services and semiconductor testing services, including front-end engineering testing, wafer probing and final testing services. The company offers packaging and testing services separately and on a turnkey basis.

    Comment?

  20. Avinger Inc (AVGR) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    May 19, 2016 | AmericanBankingNews.com

    According to Zacks, "Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox.

    Comment?

Redwood City Job Listings
View or post Redwood City job listings on Topix.
Redwood City Real Estate
News, listings, and foreclosures in Redwood City from Topix.
Redwood City Mortgages
Find mortgage rates in Redwood City on Topix.